Veracyte initiated with an Outperform at Wolfe Research
Wolfe Research initiated coverage of Veracyte (VCYT) with an Outperform rating and $50 price target Published first on TheFly – the ...
Veracyte initiated with an Outperform at Wolfe on growth, margin potential
As previously reported, Wolfe Research initiated coverage of Veracyte (VCYT) with an Outperform rating and $50 price target The genomic ...